山东药玻：公司间接控股股东或变更

Group 1 - The core point of the news is that Shandong Pharmaceutical Glass (600529) has received a notification from its controlling shareholder, Shandong Luzhong Investment, regarding a potential restructuring involving the Yiyuan County People's Government and China International Medical and Health Co., Ltd. This may lead to a change in the indirect controlling shareholder of the company [1] - The restructuring matter currently does not involve any significant asset restructuring and will not have a major impact on the company's normal production and operational activities [2] - As of now, the restructuring plan has not been finalized, and any agreement will require approval from relevant authorities, indicating uncertainty in the approval outcome [2]